{"status":"success","data":{"title":"Asthma Classification","slug":"asthma-classification","tags":null,"collection":["Pulmonology","Allergy-Immunology"],"content":"<h1 id=\"asthma-classification\">Asthma Classification</h1>\n<h1 id=\"needs-chart-images-placed-here-\">NEEDS CHART IMAGES PLACED HERE!!!</h1>\n<ul>\n<li><strong>Step 1:</strong> Short-acting beta agonist PRN</li>\n<li><strong>Step 2</strong>: Low-dose inhaled corticosteroid</li>\n<li><strong>Step 3:</strong> Low-dose inhaled corticosteroid + long-acting beta agonist, OR medium-dose inhaled corticosteroid</li>\n<li><strong>Step 4:</strong> Medium-dose inhaled corticosteroid + long-acting beta agonist</li>\n<li><strong>Step 5:</strong> High-dose inhaled corticosteroid + long-acting beta agoinst AND consider olamizumab (Xolair) for patient with allergies</li>\n</ul>\n<h2 id=\"references\">References</h2>\n<ul>\n<li><a href=\"http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf\">National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma 2007.</a></li>\n</ul>\n"}}